Safety and Efficacy of Combination Treatment for CTD-PAH
Combination therapy with ambrisentan and tadalafil may improve response in patients with connective tissue disease-associated pulmonary arterial hypertension.
Combination therapy with ambrisentan and tadalafil may improve response in patients with connective tissue disease-associated pulmonary arterial hypertension.
Switching from intravenous to oral antibiotics in patients with healthcare-associated pneumonia was found to be safe.
Smoking correlated with increased measures of left ventricular mass and worsening diastolic function.